Literature DB >> 30121135

Inhibition of microglial activation by minocycline reduced preoligodendrocyte injury in a neonatal rat brain slice model.

Junrong Huang1, Gang Liu1, Bowen Shi1, Guochen Shi1, Xiaomin He1, Zhaohui Lu1, Jinghao Zheng1, Haibo Zhang1, Huiwen Chen1, Zhongqun Zhu2.   

Abstract

BACKGROUND: Periventricular leukomalacia is a common white-matter injury after neonatal cardiac surgery; however, its potential cellular mechanism remains uncertain. There is limited study regarding periventricular leukomalacia treatment.
METHODS: A neonatal rat brain slice perfusion model was used for reproducing the condition of cardiopulmonary bypass, and oxygen glucose deprivation simulated circulatory arrest. Seven-day-old Sprague-Dawley rats were randomly divided into 7 groups: (1) control group with 36°C; (2) 60 minutes of oxygen glucose deprivation group on 15°C, 25°C, 36°C, respectively; and (3) 60 minutes of oxygen glucose deprivation group on 15°C, 25°C, 36°C, plus minocycline (10 μmol/L), respectively. Immunohistochemistry, Western blot, and inflammatory mediators were compared after the perfusion procedures in the different groups.
RESULTS: This neonatal rat brain slice perfusion with oxygen glucose deprivation model could replicate the pathophysiologic process and injury after cardiopulmonary bypass and hypothermic circulatory arrest. With the increase of oxygen glucose deprivation perfusion temperature, we found that both microglia activation and preoligodendrocyte loss increased. The application of minocycline can significantly inhibit microglial activation and preoligodendrocyte cells loss in the normothermic (36°C) and moderate hypothermia (25°C) oxygen glucose deprivation groups (P < .05), with accompanying significant decreasing microglial inflammatory productions; however, no significant improvement was found in the deep hypothermia (15°C) group.
CONCLUSIONS: The microglial activation may play a key role in preoligodendrocyte injury in the ex vivo neonatal rat brain slice perfusion and circulatory arrest model. Inhibition of microglial activation with minocycline may be an attractive target for white-matter protection during cardiopulmonary bypass and hypothermic circulatory arrest.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  congenital heart defect; microglia; minocycline; preoligodendrocyte; white-matter

Mesh:

Substances:

Year:  2018        PMID: 30121135     DOI: 10.1016/j.jtcvs.2018.06.038

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Application of a neuroscience research model to study neuroprotection in children with congenital heart disease.

Authors:  Nobuyuki Ishibashi; Richard A Jonas
Journal:  J Thorac Cardiovasc Surg       Date:  2018-07-19       Impact factor: 5.209

2.  Triptolide protects against white matter injury induced by chronic cerebral hypoperfusion in mice.

Authors:  Yu-Shan Wan; Yi You; Qian-Yun Ding; Yi-Xin Xu; Han Chen; Rong-Rong Wang; Yu-Wen Huang; Zhong Chen; Wei-Wei Hu; Lei Jiang
Journal:  Acta Pharmacol Sin       Date:  2021-04-06       Impact factor: 6.150

3.  Minocycline attenuation of rat corpus callosum abnormality mediated by low-dose lipopolysaccharide-induced microglia activation.

Authors:  Jingdong Zhang; Michael Boska; Ya Zheng; Jianuo Liu; Howard S Fox; Huangui Xiong
Journal:  J Neuroinflammation       Date:  2021-04-26       Impact factor: 8.322

4.  Generation of an Iba1-EGFP Transgenic Rat for the Study of Microglia in an Outbred Rodent Strain.

Authors:  Jonathan W VanRyzin; Sheryl E Arambula; Sydney E Ashton; Alexa C Blanchard; Max D Burzinski; Katherine T Davis; Serena Edwards; Emily L Graham; Amanda Holley; Katherine E Kight; Ashley E Marquardt; Miguel Perez-Pouchoulen; Lindsay A Pickett; Erin L Reinl; Margaret M McCarthy
Journal:  eNeuro       Date:  2021-09-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.